Temozolomide as salvage treatment in primary brain lymphomas

Methotrexate (MTX)-based chemotherapy extends survival in patients with primary brain lymphomas, but it is not clear whether multiagent chemotherapy is superior to MTX alone. Treatment options for patients with recurrent primary brain lymphoma are limited; there is no standard second-line chemothera...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Reni, M, Zaja, F, Mason, W, Perry, J, Mazza, E, Spina, M, Bordonaro, R, Ilariucci, F, Faedi, M, Corazzelli, G, Manno, P, Franceschi, E, Pace, A, Candela, M, Abbadessa, A, Stelitano, C, Latte, G, Ferreri, A J M
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2007
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360092/
https://ncbi.nlm.nih.gov/pubmed/17325700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603660
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items